519 results on '"Edwards, Dylan R."'
Search Results
2. DESNT: A Poor Prognosis Category of Human Prostate Cancer
3. Analysis of ADAMTS Effects on Cell Adhesion and Migration
4. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts
5. Visual Overview from Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
6. Supplementary Figure S2 from Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
7. Data from Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
8. Supplementary Figure Legends from Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
9. Supplementary Figure 2 from Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
10. Supplementary Figure 3 from Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
11. Supplementary Table 1 from Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
12. Supplementary Figure 1 from Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
13. Supplementary Methods from Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
14. Data from Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases
15. Supplementary Figure 4 from Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
16. Supplementary Figure 3 from Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
17. Supplementary Figure 5 from Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
18. Supplementary Figure 2 from Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12
19. Supplementary Data from Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases
20. Supplementary Figure 1 from Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
21. Data from Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
22. Supplementary Figure 1 from Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12
23. Supplementary Figure 2 from Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
24. Supplementary Figure 1 from Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
25. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment
26. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells
27. HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia
28. Tumor Fibroblast-Associated Metalloproteases
29. Novel Degradome Markers in Breast Cancer
30. Quantitative Real-Time PCR Analysis of Degradome Gene Expression
31. Proteases and Their Inhibitors in Gliomas
32. The Tissue Inhibitors of Metalloproteinases (TIMPs) : Biology and Regulation
33. Proteases in cancer drug delivery
34. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15
35. Developmental Expression of 2ar (Osteopontin) and SPARC (Osteonectin) RNA as Revealed by in situ Hybridization
36. Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill
37. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates
38. MMP-1 drives immunopathology in human tuberculosis and transgenic mice
39. Matrix metalloproteinases: a dual role in breast cancer?
40. Metalloproteinases in biology and pathology of the nervous system
41. Real-Time PCR Expression Profiling of MMPs and TIMPs
42. Matrix metalloproteinases: protective roles in cancer
43. Performance and health economic evaluation of the Mount Sinai COVID-19 serological assay identifies modification of thresholding as necessary to maximise specificity of the assay
44. ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis
45. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia
46. Matrix metalloproteinases and diseases of the CNS
47. ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma
48. Expression Profiling of Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Normal and Degenerate Human Achilles Tendon
49. Acetylation in the control of metalloproteinase expression
50. Mycobacterium tuberculosis, but Not Vaccine BCG, Specifically Upregulates Matrix Metalloproteinase-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.